Real-time enrollment status for this hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:51 AM UTC
| NCT Number | NCT06764316 |
| Recruiting Status | Recruiting |
| Condition | Hepatocellular Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 148 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Bayer |
| Last Updated on CT.gov | July 15, 2026 (2 days ago) |
As of July 17, 2026: Clinical trial NCT06764316 is currently recruiting participants. This phase1 study for hepatocellular carcinoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Bayer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06764316 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06764316 was last updated 2 days ago (July 15, 2026). HelloStudys verifies this status automatically.